NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,744,000 | -59.3% | 330,576 | -50.0% | 0.57% | -85.3% |
Q4 2017 | $6,743,000 | -29.4% | 661,045 | -36.7% | 3.91% | +28.5% |
Q3 2017 | $9,550,000 | +25.3% | 1,043,770 | 0.0% | 3.04% | +21.3% |
Q2 2017 | $7,620,000 | +1.4% | 1,043,770 | 0.0% | 2.51% | -51.0% |
Q1 2017 | $7,515,000 | +85.2% | 1,043,770 | +50.5% | 5.12% | +122.6% |
Q4 2016 | $4,057,000 | -21.4% | 693,582 | -11.6% | 2.30% | -26.6% |
Q3 2016 | $5,163,000 | -19.8% | 784,704 | +13.1% | 3.14% | -22.5% |
Q2 2016 | $6,436,000 | -14.0% | 693,582 | 0.0% | 4.05% | -8.9% |
Q1 2016 | $7,484,000 | -42.9% | 693,582 | -26.1% | 4.44% | -35.1% |
Q4 2015 | $13,105,000 | -26.4% | 938,598 | 0.0% | 6.84% | -20.8% |
Q3 2015 | $17,813,000 | – | 938,598 | – | 8.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |